---
schema_version: "secwatch.filing_event.v1"
accession: "0001625297-25-000056"
form_type: "8-K"
ticker: "INDV"
cik: "0001625297"
company_name: "Indivior Pharmaceuticals, Inc."
filed_at: "2025-08-22T23:59:59+00:00"
generated_at: "2026-05-17T10:33:54.781964+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Indivior PLC enters new employment agreements with CFO Ryan Preblick; no changes to compensation or role

## Summary
- New employment agreement for CFO Ryan Preblick, effective Jan 1, 2025, aligns with current U.S. executive forms.
- No changes to compensation, responsibilities, or title from prior 2020 agreement.
- Annual base salary remains $558,819; cash bonus target at 60% of base salary (max 120%).
- LTIP annual award anticipated at 400% of base salary, subject to Compensation Committee discretion.

## SEC filing metadata
- accession: 0001625297-25-000056
- form_type: 8-K
- ticker: INDV
- cik: 0001625297
- company_name: Indivior Pharmaceuticals, Inc.
- filed_at: 2025-08-22T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000056/0001625297-25-000056-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1625297/000162529725000056/indv-20250820.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001625297-25-000056
- JSON: https://secwatch.observer/filing/0001625297-25-000056.json
- Plain text: https://secwatch.observer/filing/0001625297-25-000056.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.